"After a long battle, Pfizer drops the price of its Prevnar vaccine to humanitarian groups", 11 Nov 2016

…Pfizer has lowered the price of its pneumococcal vaccine to non-governmental organizations that supply poor countries. The company will sell the newest version of its Prevnar 13 vaccine for $3.10 a dose….[T]he price drop comes after a protracted dispute with Doctors Without Borders…The nonprofit has repeatedly criticized Pfizer for failing to lower its price and make it more widely available to humanitarian organizations that work in poor and developing countries…In a report…Doctors Without Borders maintained pneumococcal vaccines were 68 times more expensive than in 2001 and attributed 45 percent of the increased cost to pricing. GlaxoSmithKline also sells a vaccine but recently agreed to lower its price and make it available to humanitarian groups. Pneumococcal disease kills about 1 million children per year, mostly in poor and developing nations…Doctors Without Borders does plan to accept the offer once details are reviewed, such as any stipulations on the amount of vaccine that must be purchased…